For instance, systematic comparisons between HCC and NNMT-high malignancies (e.g., breast and ovarian cancers) could delineate conserved pathways (e.g., NAD+ salvage mechanisms) versus liver-specific vulnerabilities, such as the GNMT–NNMT regulatory axis in methionine cycle homeostasis. The gene discussed is GNMT; the disease is ovarian carcinoma.